Quantcast

Latest Novartis Stories

2014-05-01 20:24:02

DUBLIN, May 1, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/dfhjv9/global_orphan) have announced the addition of the "Global Orphan Drugs Market 2014-2018" [http://www.researchandmarkets.com/research/dfhjv9/global_orphan ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The analysts forecast the Global Orphan Drugs market to grow at a CAGR of 5.67 percent over the period 2013-2018....

2014-04-29 20:23:44

LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:The World Market for Orphan Drugshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/world_market_orphan_drugs_1.htmlIn recent years, there has been a substantial increase in the number of drugs available to treat rare ("orphan") diseases. This comprehensive report, The World Market for Orphan Drugs, looks at this trend and provides estimates for the market opportunity in the U.S.,...

2014-04-29 12:34:30

DUBLIN, Apr. 29, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/kmmjl6/pet_medications) has announced the addition of the "Pet Medications in the U.S.: Over-the-Counter and Prescription Remedies as Consumer Products, 3rd Edition" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The market for pet medications in the U.S. is experiencing considerable activity. Longtime flea and tick leader Frontline (from Merial) is finally...

2014-04-29 08:39:29

BASEL, Switzerland, April 29, 2014 /PRNewswire/ -- At the Annual General Meeting of Syngenta AG held on April 29, 2014, the 861 shareholders representing 48.48% of the total shares approved all the motions proposed by the Board of Directors. The shareholders approved motions including a gross dividend of CHF 10.00 per share, an increase of 5% over the previous year. For the first time, in accordance with the Ordinance against Excessive Compensation at Listed...

2014-04-24 23:06:13

Healthcare market research firm Kalorama Information says the pharmaceutical giant Novartis benefits a bit more from its recently announced partnership with Glaxo Smith Kline. New York, NY (PRWEB) April 24, 2014 Healthcare market research firm Kalorama Information says the pharmaceutical giant Novartis benefits a bit more from its recently announced partnership with Glaxo Smith Kline....

2014-04-24 12:28:43

-- Global release of photo e-book on World Meningitis Day in Toronto -- World-wide campaign raises awareness of meningococcal disease TORONTO, April 24, 2014 /CNW/ - To mark World Meningitis Day, world-renowned photographer and children's advocate Anne Geddes today released her latest photo book - Protecting Our Tomorrows: Portraits of Meningococcal Disease in Toronto. Protecting Our Tomorrows: Portraits of Meningococcal Disease is a collection of inspirational images of 15...

2014-04-23 12:31:04

Three Phase 3 Trials Advancing in Patients with BRAF Melanoma, NRAS Melanoma and Low-Grade Serous Ovarian Cancer BOULDER, Colo., April 23, 2014 /PRNewswire/ -- Following the recent announcement by Novartis and GlaxoSmithKline that they have entered into a definitive agreement to exchange certain assets, Array BioPharma Inc. (NASDAQ: ARRY) reports that Novartis has indicated that it will continue to honor its obligations under the Array-Novartis agreement relating to binimetinib...

2014-04-23 08:31:05

-- Number one ranking acknowledges Novartis Pharmaceuticals Corporation's commitment to and leadership in diversity and inclusion EAST HANOVER, N.J., April 23, 2014 /PRNewswire/ -- Novartis Pharmaceuticals Corporation (NPC) has been named the leading company on the 14(th) annual DiversityInc Top 50 Companies for Diversity listing. DiversityInc announced the results of its 2014 Top 50 Companies for Diversity on April 22 at an awards ceremony in New York, NY. "We are extremely...

2014-04-23 08:27:22

Novartis Pharmaceuticals Corporation Ranked No. 1 NEW YORK, April 23, 2014 /PRNewswire/ -- DiversityInc announced the results for its 14th annual Top 50 Companies for Diversity rankings before a gathering of more than 750 attendees last evening at Cipriani Wall Street. More than a thousand public and privately held companies competed for spots on the coveted list. Novartis Pharmaceuticals Corporation jumped from a sixth-place finish in 2013 to claim this year's top slot. Other companies...

2014-04-22 00:21:28

- $5.4 billion deal creates world's second-largest animal health company. INDIANAPOLIS, April 22, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced an agreement to acquire Novartis Animal Health for approximately $5.4 billion in an all-cash transaction that will strengthen and diversify Lilly's own animal health business, Elanco. Upon completion of the acquisition, Elanco will be the second-largest animal health company in terms of global revenue, will...


Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related